F432-0591 Screening compound: N-{6-[(4-methoxyphenyl)sulfanyl]-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl}-2,3-dihydro-1H-indene-5-sulfonamide

F432-0591 Screening compound: N-{6-[(4-methoxyphenyl)sulfanyl]-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl}-2,3-dihydro-1H-indene-5-sulfonamide
F432-0591 Screening compound: N-{6-[(4-methoxyphenyl)sulfanyl]-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl}-2,3-dihydro-1H-indene-5-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F432-0591
N-{6-[(4-methoxyphenyl)sulfanyl]-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl}-2,3-dihydro-1H-indene-5-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F432-0591

Molecular Formula

C25H25N3O4S2 (C25 H25 N3 O4 S2)

Compound Name

N-{6-[(4-methoxyphenyl)sulfanyl]-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl}-2,3-dihydro-1H-indene-5-sulfonamide

IUPAC name

N-{6-[(4-methoxyphenyl)sulfanyl]-13-dimethyl-2-oxo-23-dihydro-1H-13-benzodiazol-5-yl}-23-dihydro-1H-indene-5-sulfonamide

SMILES

CN(c(c(N1C)c2)cc(NS(c3cc(CCC4)c4cc3)(=O)=O)c2Sc(cc2)ccc2OC)C1=O

InChI

InChI=1S/C25H25N3O4S2/c1-27-22-14-21(26-34(30,31)20-12-7-16-5-4-6-17(16)13-20)24(15-23(22)28(2)25(27)29)33-19-10-8-18(32-3)9-11-19/h7-15,26H,4-6H2,1-3H3

InChI Key

QSELNHSNZRGPKA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27128610

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

495.62

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.506

Distribution Coefficient, logD

5.495

Water Solubility, LogSw

-5.33

Polar Surface Area

65.434

Acid Dissociation Constant (pKa)

9.00

Base Dissociation Constant (pKb)

-2.34

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.00

F432-0591 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Immune system
  • Cancer
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F432-0591 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F432-0591?
Check Price and Availability of F432-0591, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F432-0591 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F432-0591
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F432-0591
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F432-0591 available by request